Home » Topics » Disease categories and therapies » Immune

Immune
RSS

FDA recommends approval of Bristol-Myers Squibb's belatacept

March 3, 2010

Inovio to begin clinical trial of H5N1 flu DNA vaccine in Korea

March 3, 2010

Ambit Biosciences claims novel Janus kinase inhibitors

March 1, 2010

Bristol-Myers Squibb discloses new transcription factor AP-1 inhibitors

March 1, 2010

FDA approves Prevnar 13 for prevention of pneumococcal disease in infants and children

Feb. 25, 2010

Five Prime Therapeutics reports milestone for immunology-related therapeutic program

Feb. 25, 2010

Ablynx awarded grant to progress ALX- 0061 into clinical development

Feb. 22, 2010

Octapharma initiates phase III trial of high-purity intravenous immunoglobulin

Feb. 22, 2010

Dynavax and GSK select candidate in endosomal TLR inhibitor program

Feb. 19, 2010

Quark granted orphan drug designation for QPI-1002 in DGF in kidney transplants

Feb. 17, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...